ACHP Statement on CY 2025 Advance Notice for Medicare Advantage and Part D
ACHP issued a statement in response to CMS’ CY 2025 Advance Notice for Medicare Advantage and Part D.
ACHP issued a statement in response to CMS’ CY 2025 Advance Notice for Medicare Advantage and Part D.
ACHP strongly supports CMS’ proposed CY 2025 Medicare C & D rule, which supports consumer choice and caps broker compensation.
ACHP supports CMS’ proposals to reform broker agent compensation and urges immediate implementation to support and improve the Medicare Advantage and Part D programs.
ACHP member companies offering MA plans once again outpaced competitors in CMS Star Ratings, leading on critical health measures and overall satisfaction.
ACHP sent a letter to the Senate Finance Committee on efforts to crack down on misleading marketing practices and unchecked broker compensation in the Medicare Advantage program.
